Evelo Biosciences (EVLO) Stock Price, News & Analysis
Company Description
Evelo Biosciences (OTC Link: EVLO) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $9.5K.
For FY2022, Evelo Biosciences reported net income of -$114.5M and diluted earnings per share of -$1.31.
This page collects what Stock Titan holds for EVLO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Evelo Biosciences (EVLO) stock last closed at $0.0000. At a market capitalization of $9.5K, EVLO is classified as a micro-cap stock with approximately 18.9M shares outstanding.
Latest News
Evelo Biosciences has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, earnings, private placement, stock split, conferences. View all EVLO news →
SEC Filings
Financial Highlights
operating income reached -$108.5M, and net income was -$114.5M. Diluted earnings per share stood at -$1.31. The company generated -$101.2M in operating cash flow. With a current ratio of 4.16, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Evelo Biosciences (EVLO) currently stands at 6.7 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 31.6 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Evelo Biosciences (EVLO) currently stands at 31.6 days, up 26.3% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 211.8% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 156.7 days.
EVLO Company Profile & Sector Positioning
Evelo Biosciences (EVLO) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing EVLO often look at related companies in the same sector, including Scopus Biopharma Inc. (SCPS), Renovacare (RCAR), Virpax Pharmaceuticals Inc (VRPX), Statera Biopharma Inc (STAB), and Q Biomed (QBIO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EVLO's relative position within its industry.